Insider Transactions Reported by 17 Insiders of Beam Therapeutics Inc.

Symbol
BEAM on Nasdaq
Location
Cambridge, MA

Insiders trading volume in the past year

Beam Therapeutics Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
ARCH Venture Partners IX, LLC 10%+ Owner $77,929,225 30 Jun 2021
Kristina Burow Director $72,993,124 06 Jun 2023
FMR LLC Other*, 10%+ Owner $48,071,330 -$1,003,913 -2% 27 Oct 2025
John M. Evans CEO, Director $30,300,002 -$1,791,007 -5.6% 01 Oct 2025
Giuseppe Ciaramella President $5,198,578 -$136,418 -2.6% 01 Apr 2025
Amy Simon Chief Medical Officer $3,578,593 -$571,797 -14% 31 Dec 2025
Christine Bellon Chief Legal Officer $3,388,579 -$487,255 -13% 31 Dec 2025
Terry-Ann Burrell Chief Financial Officer $3,133,858 26 Apr 2024
Sravan Kumar Emany Chief Financial Officer $1,997,432 -$170,567 -7.9% 31 Dec 2025
Bethany J. Cavanagh SVP, Finance and Treasurer $1,568,423 -$286,831 -15% 01 Oct 2025
Chirfi Guindo Director $953,698 04 Jun 2025
JOHN MARAGANORE Director $563,982 04 Jun 2025
GRAHAM K. COOPER Director $563,982 04 Jun 2025
Mark Fishman Director $563,982 04 Jun 2025
Christi Shaw Director $563,982 04 Jun 2025
Carole Ho Director $563,982 04 Jun 2025
Kathleen E. Walsh Director $403,381 04 Jun 2025

Recent Insider Transactions by Companies or Individuals for Beam Therapeutics Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.